Aura Biosciences, Inc. Common Stock (AURA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Aura Biosciences, Inc. Common Stock (AURA) is listed on Nasdaq, where it has traded since October 29, 2021.
- Listed On
- Nasdaq
- Listed Since
- October 29, 2021
- Employees
- 113
- Market Cap
- $622M
About Aura Biosciences, Inc. Common Stock
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 142 institutions reported holding AURA, with 95.4 million shares worth $677.3 million in aggregate. The largest reported holder was Tcg Crossover Management, with 9.5 million shares worth $67.7 million. Of the 5 largest holders listed below, 1 opened a new position in AURA and 4 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Tcg Crossover Management | 9,533,333 | $68M | New position |
| Suvretta Capital Management | 7,206,217 | $51M | Added 64.79% |
| Frazier Life Sciences Management, | 7,100,000 | $50M | Added 39.22% |
| Vanguard | 5,646,570 | $40M | Added 83.8% |
| Long Focus Capital Management | 5,119,582 | $36M | Added 10.82% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AURA?
Aura Biosciences, Inc. Common Stock (AURA) is listed on Nasdaq, where it has traded since October 29, 2021.
Who are the largest institutional holders of AURA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AURA were Tcg Crossover Management, Suvretta Capital Management and Frazier Life Sciences Management,.
How many institutions own AURA?
142 institutions reported a position in AURA for the quarter ended June 30, 2026, worth $677.3 million in total.
Did institutions buy or sell AURA last quarter?
Of the 5 largest reported holders, 1 opened a new position in AURA and 4 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for AURA.
Every reported institutional holder, plus insider and congressional trades in AURA, on SentiSense.